Metraipolis › archive › dc_a45aba013566
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers for Cardiovascular and Renal Protection in Type 2 Diabetes: A Systematic Review… — Europe PMC PMID:41798419
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41798419
- DOI
- 10.7759/cureus.103029
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T02:42:28.233Z
- SHA-256 of the archived text
ac018dc060d76e53357106c763ed333a681edbb4eb14c91655c77b8196c4d6e1- Stable URL of this page
https://metraipolis.com/documento/dc_a45aba013566
How to cite
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers for Cardiovascular and Renal Protection in Type 2 Diabetes: A Systematic Review… — Europe PMC PMID:41798419 — Europe PMC (en), https://europepmc.org/article/MED/41798419 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a45aba013566 (Metraipolis archive dc_a45aba013566, sha256 ac018dc060d76e53357106c763ed333a681edbb4eb14c91655c77b8196c4d6e1)
BibTeX
@misc{dca45aba013566,
title = {Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers for Cardiovascular and Renal Protection in Type 2 Diabetes: A Systematic Review… — Europe PMC PMID:41798419},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41798419},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a45aba013566; sha256 ac018dc060d76e53357106c763ed333a681edbb4eb14c91655c77b8196c4d6e1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41798419. Agents can read the archived copy with the MCP tool read_document.